Andere Sprachen Ikena Oncology, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.06.2024			% 5 Tage	% 1. Jan.
1.64 ^USD	-2.38%		-3.53%	-16.75%

29.05.	IKENA ONCOLOGY, INC. : Bewertung von HC Wainwright kaufen	ZM
29.05.	IKENA ONCOLOGY, INC. : Von Wedbush auf neutral herabgestuft	ZM

Ikena Oncology to Cut Jobs, Explore Options, End IK-930 Program; Shares Rise After Hours	28.05.
UPDATE – Ikena Oncology Announces Strategic Update	28.05.
Ikena Oncology, Inc. Announces Workforce Reduction	28.05.
Ikena Oncology, Inc. Announces Discontinue Development of IK-930	28.05.
Ikena Oncology Announces Strategic Update	28.05.
Ikena Oncology Announces Strategic Update	28.05.
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update	13.05.
Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
Ikena Oncology : Corporate Presentation - April 2024	16.04.
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10.04.
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10.04.
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results	12.03.
Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12.03.
North American Morning Briefing : Inflation Data -2-	12.03.
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference	27.02.
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer	21.02.
Ikena Oncology, Inc. Announces Executive Changes	21.02.
Ikena Oncology to Cut 35% of Workforce to Extend Cash Runway Into H2 2026	18.01.
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates	18.01.
Ikena Oncology, Inc. Provides Corporate Updates	18.01.

Keine Ergebnisse zu dieser Suche